| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |